The leading cause of death among women globally is cardiovascular disease. Despite this, cardiovascular disease in women remains understudied, underdiagnosed, and undertreated. Join our MSL co-hosts Dalila Masic, PharmD and Kinsi Brindley, PharmD as they have a conversation with Dr. Annabelle Volgman, MD, FACC, FAHA. What can we do to help close the gender gap for women with atrial fibrillation? Dr. Volgman shares her insights that she has established through years of experience and research in treating women with cardiovascular disease.

Resources mentioned in episode:

1. WomenHeart: https://www.womenheart.org/

Supporting literature from episode:

1. Women and Atrial Fibrillation Review Article: https://ncbi.nlm.nih.gov/pmc/articles/PMC8281363/
2. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study: https://pubmed.ncbi.nlm.nih.gov/16198847/
3. Gendered social determinists of health and risk of major adverse outcomes in atrial fibrillation: https://www.jacc.org/doi/10.1016/S0735-1097%2823%2902103-4
4. Sex Differences in Early Rhythm Control of Atrial Fibrillation in the EAST-AFNET 4 Trial: https://www.sciencedirect.com/science/article/pii/S073510972207663X?via%3Dihub
5. Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation: https://www.ahajournals.org/doi/full/10.1161/JAHA.121.024233

Music: Spark of Inspiration by Shane Ivers - https://www.silvermansound.com